News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Conference News ESC 2017 Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women Michael O'Riordan August 26, 2017
News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Conference News ESC 2015 Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes Yael L. Maxwell September 01, 2015
News Conference News ESC 2014 IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI Todd Neale September 02, 2014
News Conference News ESC 2014 Observational Studies Ask How Much Medication Adherence Matters After MI Caitlin E. Cox August 31, 2014
News Conference News ESC 2014 APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI Yael L. Maxwell August 31, 2014
News Conference News ESC 2014 Post-Acute MI Survival Improving for Elderly Patients in France Todd Neale August 30, 2014
News Conference News ESC 2012 STEMI Patient Population Evolves Over 15 Years Yael L. Maxwell August 27, 2012
News Conference News Japanese ACS Patients Fare Better with High Rates of Intensive Treatment September 01, 2011
News Conference News Halting Clopidogrel in First Year Following Acute MI Hazardous September 01, 2011
News Conference News ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin August 29, 2011